BIOMERICA INC Logo

BIOMERICA INC

Develops diagnostic tests for GI, inflammatory diseases, and diabetes for lab and at-home use.

BMRA | US

Overview

Corporate Details

ISIN(s):
US09061H3075
LEI:
Country:
United States of America
Address:
17571 VON KARMAN AVENUE, 92614 IRVINE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Biomerica Inc. is a global biomedical technology company that develops, patents, manufactures, and markets advanced diagnostic and therapeutic products. The company's primary research and development is focused on gastrointestinal and inflammatory diseases, with additional products for diabetes and esoteric testing. Its portfolio includes over 80 diagnostic products, designed for both laboratory and at-home use, which facilitate the early detection and monitoring of medical conditions. Biomerica's stated mission is to enhance patient health and well-being while helping to reduce overall healthcare costs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOMERICA INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOMERICA INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOMERICA INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
IMPACT BIOMEDICAL INC. Logo
Develops biopharma, preservatives, and bioplastics for healthcare and pathogen protection.
United States of America IBO
Imunon, Inc. Logo
Developing DNA-based immunotherapies for oncology and infectious diseases.
United States of America IMNN
IN8BIO, INC. Logo
Clinical-stage biopharma developing gamma-delta T cell therapies for solid & hematological tumors.
United States of America INAB
Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.
United Kingdom INC
INCYTE CORP Logo
Develops proprietary therapeutics for serious unmet needs in oncology and inflammation.
United States of America INCY
Indaptus Therapeutics, Inc. Logo
Develops immunotherapies using engineered bacteria to treat cancer and viral infections.
United States of America INDP
Indivior PLC Logo
Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.
United Kingdom INDV
INDIVIOR PLC Logo
A pharmaceutical firm developing medicines for addiction and serious mental illnesses.
United States of America INDV
Infant Bacterial Therapeutics Logo
Develops live bacterial medicines to prevent rare, severe gut diseases in premature infants.
Sweden IBT
InflaRx N.V. Logo
Develops complement system inhibitors for severe inflammatory diseases and immuno-dermatology.
United States of America IFRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.